Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
BMC Primary Care|September 26, 2025
Shift in therapeutic approaches in patients with hypercholesterolemia - a secondary data analysisElena Zink, Jost Steinhäuser, Paul-Georg Blickle, et al.Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 3, 2021
Experiences made by family physicians managing patients with SARS-CoV-2 infection during spring 2020 - a cross-sectional analysisChristoph Strumann, Wolfgang C G von Meißner, Paul-Georg Blickle, et al.International Journal of Emergency Medicine|August 8, 2025
Utilization of acute medical services in general practice: a retrospective routine data analysisChristoph Strumann, Wolfgang C G von Meißner, Paul-Georg Blickle, et al.BMC Primary Care|February 11, 2024
Quality of care in patients with hypertension: a retrospective cohort study of primary care routine data in GermanyChristoph Strumann, Nicola J Engler, Wolfgang C G von Meissner, et al.Molecular and Cellular Pediatrics|May 26, 2026
Sex differences in the long-term tolerability of BNT162b2 in children and adolescentsJeanne Moor, Vivien Grieshaber, Nicole Toepfner, et al.JMIR Formative Research|December 10, 2025
Information Extraction of Doctoral Theses Using Two Different Large Language Models vs Health Services Researchers: Development and Usability StudyJonas Cittadino, Pia Traulsen, Teresa Schmahl, et al.Biology of Sex Differences|September 26, 2024
Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort studyJeanne Moor, Nicole Toepfner, Wolfgang C G von Meißner, et al.Deutsches Arzteblatt International|March 18, 2025
The Long-Term Tolerability of BNT162b2 in Children and Adolescents (The CoVacU18 Study)Vivien Grieshaber, Christoph Strumann, Sarah Holzwarth, et al.JAMA Network Open|October 18, 2022
Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 YearsNicole Toepfner, Wolfgang C G von Meißner, Christoph Strumann, et al.Pageof 3